UK Updates Regulations to Speed Up Clinical Trials
英國更新法規以加速臨床試驗
The United Kingdom has officially launched the most significant overhaul of its clinical trial regulations in twenty years.
聯合王國已正式啟動二十年來最重大的臨床試驗法規改革。
Enacted on 28 April 2026, the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 aim to transform the UK into a premier destination for global research.
該法規於2026年4月28日生效，即《2025年人類用藥物（臨床試驗）（修訂）法規》，旨在將聯合王國打造為全球研究的首選目的地。
Key changes include a fast-track notification route for low-risk studies and a 14-day assessment timeline for Phase 1 trials.
重要變革包括針對低風險研究的快速通知管道，以及第一期臨床試驗為期14天的評估時程。
The reforms also embrace modern science by allowing for innovative methods like computer-model simulations.
此項改革亦擁抱現代科學，允許採用計算機模擬等創新方法。
This strategic move aims to streamline the path from application to recruitment, ultimately boosting the UK’s competitive edge in the life sciences sector and ensuring that the country remains at the forefront of medical innovation.
此一策略性舉措旨在簡化從申請到招募的流程，最終提升聯合王國在生命科學領域的競爭優勢，並確保該國持續站在醫療創新的最前線。
